Proenkephalin and risk of developing chronic kidney disease: the Prevention of Renal and Vascular End-stage Disease study

References

• Awad, H., et al., 2012. Endogenous opioids in wound-site neutrophils of sternotomy patients. PLoS One, 7 (10), e47569.
   PubMed Web of Science ®Google Scholar
• Cook, N.R., 2007. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation, 115 (7), 928–935.
   PubMed Web of Science ®Google Scholar
• Danesh, J., et al., 2004. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. The new England journal of medicine, 350 (14), 1387–1397.
   PubMed Web of Science ®Google Scholar
• de Jong, P.E. and Curhan, G.C., 2006. Screening, monitoring, and treatment of albuminuria: public health perspectives. Journal of the American Society of Nephrology, 17 (8), 2120–2126.
   PubMed Web of Science ®Google Scholar
• Denning, G.M., et al., 2008. Proenkephalin expression and enkephalin release are widely observed in non-neuronal tissues. Peptides, 29 (1), 83–92.
   PubMed Web of Science ®Google Scholar
• Ernst, A., et al., 2006. Proenkephalin A 119–159, a stable proenkephalin a precursor fragment identified in human circulation. Peptides, 27 (7), 1835–1840.
   PubMed Web of Science ®Google Scholar
• Grubb, A., et al., 2010. First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clinical chemistry and laboratory medicine: CCLM/FESCC, 48 (11), 1619–1621.
   PubMed Web of Science ®Google Scholar
• Halbesma, N., et al., 2008. Gender differences in predictors of the decline of renal function in the general population. Kidney international, 74 (4), 505–512.
   PubMed Web of Science ®Google Scholar
• Harrell, F.E.J., 2001. Regression modeling strategies. Anonymous, ed. New York: Springer.
   Google Scholar
• Hillege, H.L., et al., 2001. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. Journal of internal medicine, 249 (6), 519–526.
   PubMed Web of Science ®Google Scholar
• Inker, L.A., et al., 2012. Estimating glomerular filtration rate from serum creatinine and cystatin C. The new England journal of medicine, 367 (1), 20–29.
   PubMed Web of Science ®Google Scholar
• Kieneker, L.M., et al., 2017. Plasma proenkephalin and poor long-term outcome in renal transplant recipients. Transplantation direct, 3 (8), e190.
   PubMed Web of Science ®Google Scholar
• Kiil, F., 1977. Renal energy metabolism and regulation of sodium reabsorption. Kidney international, 11 (3), 153–160.
   PubMed Web of Science ®Google Scholar
• Koenig, W., et al., 2003. Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987. American journal of epidemiology, 158 (4), 357–364.
   PubMed Web of Science ®Google Scholar
• Koning, S.H., et al., 2015. Alcohol consumption is inversely associated with the risk of developing chronic kidney disease. Kidney international, 87 (5), 1009–1016.
   PubMed Web of Science ®Google Scholar
• Levey, A.S., et al., 2015. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA, 313 (8), 837–846.
   PubMed Web of Science ®Google Scholar
• Levey, A.S., et al., 2011. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney international, 80 (1), 17–28.
   PubMed Web of Science ®Google Scholar
• Levey, A.S., et al., 2009. A new equation to estimate glomerular filtration rate. Annals of internal medicine, 150 (9), 604–612.
   PubMed Web of Science ®Google Scholar
• Marino, R., et al., 2015. Diagnostic and short-term prognostic utility of plasma pro-enkephalin (pro-ENK) for acute kidney injury in patients admitted with sepsis in the emergency department. Journal of nephrology, 28 (6), 717–724.
   PubMed Web of Science ®Google Scholar
• McTavish, N., et al., 2007. Proenkephalin assists stress-activated apoptosis through transcriptional repression of NF-kappaB- and p53-regulated gene targets. Cell death & differentiation, 14 (9), 1700–1710.
   PubMed Web of Science ®Google Scholar
• Ng, L.L., et al., 2014. Proenkephalin and prognosis after acute myocardial infarction. Journal of the American College of Cardiology, 63 (3), 280–289.
   PubMed Web of Science ®Google Scholar
• Ng, L.L., et al., 2017. Proenkephalin, renal dysfunction, and prognosis in patients with acute heart failure: a GREAT network study. Journal of the American College of Cardiology, 69 (1), 56–69.
   PubMed Web of Science ®Google Scholar
• Oterdoom, L.H., et al., 2009. Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population. Atherosclerosis, 207 (2), 534–540.
   PubMed Web of Science ®Google Scholar
• Ovadia, H., et al., 1996. Molecular characterization of immune derived proenkephalin mRNA and the involvement of the adrenergic system in its expression in rat lymphoid cells. Journal of neuroimmunology, 68 (1–2), 77–83.
   PubMed Web of Science ®Google Scholar
• Schulz, C.A., et al., 2017. High level of fasting plasma proenkephalin-a predicts deterioration of kidney function and incidence of CKD. Journal of the American Society of Nephrology, 28 (1), 291–303.
   PubMed Web of Science ®Google Scholar
• Sezen, S.F., et al., 1998. Renal excretory responses produced by the delta opioid agonist, BW373U86, in conscious rats. The journal of pharmacology and experimental therapeutics, 287 (1), 238–245.
   PubMed Web of Science ®Google Scholar
• Shah, K.S., et al., 2015. Proenkephalin predicts acute kidney injury in cardiac surgery patients. Clinical nephrology, 83 (1), 29–35.
   PubMed Web of Science ®Google Scholar
• Smith, R., et al., 1981. Studies on circulating met-enkephalin and beta-endorphin: normal subjects and patients with renal and adrenal disease. Clinical endocrinology, 15 (3), 291–300.
   PubMed Web of Science ®Google Scholar
• van den Brink, O.W., et al., 2003. Endogenous cardiac opioids: enkephalins in adaptation and protection of the heart. Heart, lung & circulation, 12 (3), 178–187.
   PubMedGoogle Scholar
• Verhave, J.C., et al., 2004. Sodium intake affects urinary albumin excretion especially in overweight subjects. Journal of internal medicine, 256 (4), 324–330.
   PubMed Web of Science ®Google Scholar
• Zoccali, C., et al., 1987. Plasma met-enkephalin and leu-enkephalin in chronic renal failure. Nephrology, dialysis, transplantation, 1 (4), 219–222.
   PubMedGoogle Scholar